These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. New perspectives in cardiopulmonary therapeutics: receptor-selective adrenergic drugs. Adams HR J Am Vet Med Assoc; 1984 Nov; 185(9):966-74. PubMed ID: 6150925 [TBL] [Abstract][Full Text] [Related]
5. [Role of sympathomimetic amines in the treatment of shock]. Darragon T; Lhoste F; Regnier B; Lemaire F; Legall JR Anesth Analg (Paris); 1977; 34(2):249-57. PubMed ID: 19996 [No Abstract] [Full Text] [Related]
6. Epinephrine for acute decompensated heart failure and low output state: friend or foe? Morici N; Sacco A; Oliva F; Ferrari S; Paino R; Milazzo F; Frigerio M; Pirola R; Klugmann S; Mafrici A Int J Cardiol; 2011 Jun; 149(3):384-5. PubMed ID: 21439660 [No Abstract] [Full Text] [Related]
7. [Adrenergic alpha-receptor blockaders and direct arteriolar vasodilators in treatment of chronic cardiac insufficiency]. Novikov SV; Mareev VIu Ter Arkh; 1983; 55(5):135-40. PubMed ID: 6137073 [No Abstract] [Full Text] [Related]
8. [Alpha and beta sympathomimetics. Principles and rules of use]. Weissenburger J; Détienne JP Rev Prat; 1995 Mar; 45(6):753-62. PubMed ID: 7754314 [No Abstract] [Full Text] [Related]
9. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity. Svendsen TL J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of hypertension with the alpha- and beta-adrenergic blockader trandat]. Erina EV; Charyev KhE; Lediashova GA; Smolenskiĭ AV Ter Arkh; 1983; 55(9):43-8. PubMed ID: 6314576 [No Abstract] [Full Text] [Related]
11. [Changes in the hypophyseo-thyroid system in patients with circulatory insufficiency after treatment with digoxin]. Aleksandrova TN; Masenko VP; Titov VN; Zyrianov AM Ter Arkh; 1983; 55(9):83-8. PubMed ID: 6635985 [No Abstract] [Full Text] [Related]
12. [Concept for therapy of heart failure in heart surgery]. Zerkowski HR; Günnicker M; Marggraf G; Reidemeister JC Z Kardiol; 1994; 83 Suppl 2():55-61. PubMed ID: 8091825 [TBL] [Abstract][Full Text] [Related]
13. Sympathomimetic amines: potential clinical applications in ischemic heart disease. Goldberg LI; Rajfer SI Am Heart J; 1982 Apr; 103(4 Pt 2):724-9. PubMed ID: 6278912 [TBL] [Abstract][Full Text] [Related]
14. [Use of sympathomimetic amines in the newborn infant: our experience]. Parisi F; Corno A; La Vigna G; Catena G; Marcelletti C G Ital Cardiol; 1984 Aug; 14(8):586-8. PubMed ID: 6500219 [No Abstract] [Full Text] [Related]
15. Noradrenergic responses in rat hippocampus: electrophysiological actions of direct- and indirect-acting sympathomimetics in the in vitro slice. Mueller AL; Kirk KL; Hoffer BJ; Dunwiddie TV J Pharmacol Exp Ther; 1982 Dec; 223(3):599-605. PubMed ID: 6128402 [TBL] [Abstract][Full Text] [Related]
16. [Cardiotonic drugs in acute heart failure]. Richard C Rev Prat; 1989 May; 39(16):1422-9. PubMed ID: 2740795 [No Abstract] [Full Text] [Related]
17. [Use of the vasodilator molsidomin in the treatment of chronic cardiac insufficiency]. Mareev VIu; Sazonova LN; Grigor'iants RA; Lobova NM; Irani RM Ter Arkh; 1983; 55(9):76-80. PubMed ID: 6688891 [No Abstract] [Full Text] [Related]
18. [Efficacy of nitrates in the treatment of patients with cardiac insufficiency]. Gorb IuG Ter Arkh; 1983; 55(9):73-6. PubMed ID: 6635983 [No Abstract] [Full Text] [Related]
19. Cardiac hypertrophy induced by alpha- and beta-adrenergic receptor stimulation. Zimmer HG; Kolbeck-Ruhmkorff C; Zierhut W Cardioscience; 1995 Mar; 6(1):47-57. PubMed ID: 7605896 [TBL] [Abstract][Full Text] [Related]